Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,028 | 1,808 | 9 | 3,702 | 109 |
| Marketable Securities | N/A | N/A | N/A | 3,808 | N/A |
| TOTAL | $5,615 | $2,934 | $312 | $8,129 | $674 |
| Non-Current Assets | |||||
| PPE Net | 4 | 8 | 4 | N/A | 2 |
| Other Non-Current Assets | 120 | 14 | 67 | 206 | 279 |
| TOTAL | $124 | $22 | $71 | $206 | $281 |
| Total Assets | $5,739 | $2,956 | $383 | $8,335 | $955 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 897 | 1,410 | 1,294 | 918 | 1,226 |
| Accrued Expenses | 691 | 1,270 | 36 | 1,430 | 847 |
| Other current liabilities | N/A | 3 | 5 | 97 | 105 |
| TOTAL | $1,636 | $2,697 | $1,994 | $2,445 | $2,225 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 14 |
| Other Non-Current Liabilities | 71 | 0 | 14 | 72 | 170 |
| TOTAL | $71 | $N/A | $14 | $72 | $184 |
| Total Liabilities | $1,707 | $2,697 | $2,008 | $2,517 | $2,409 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 525 | 14 | 0 | 0 | N/A |
| Retained earnings | -39,740 | -31,533 | -18,496 | -21,902 | -12,599 |
| Other shareholders' equity | 0 | 0 | 0 | -2 | 0 |
| TOTAL | $4,032 | $259 | $-1,625 | $5,818 | $-1,454 |
| Total Liabilities And Equity | $5,739 | $2,956 | $383 | $8,335 | $955 |